Login / Signup
Engineered IFN-α and anti-PDL1 containing compounds to target the liver and restore antiviral protection for HBV cure.
Paola Fisicaro
Published in:
Gut (2022)
Keyphrases
</>
hepatitis b virus
dendritic cells
immune response
liver failure